Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 13 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Ahmedabad

← All India trials

Every active and recruiting clinical study with an investigative site in India — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

3

Recruiting now

8

Active studies

Active Phase 4

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb · started 2025-09-04

📍 Hyderabad · Ahmedabad · Surat · Gurgaon · Belagavi · Mangalore

NCT07004972 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche · started 2023-06-28

📍 Hyderabad · Ahmedabad · Faridabad · Hubli · Nagpur · Pune

NCT05878769 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Bristol-Myers Squibb · started 2023-01-12

📍 Ahmedabad · Hubli · Mysore · Nagpur · Vellore · Hyderabad

NCT05620407 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Obesity, Overweight
Eli Lilly and Company · started 2022-10-11

📍 Ahmedabad · Bikaner · Hyderabad · Lucknow · Ludhiana · Mumbai

NCT05556512 on ClinicalTrials.gov ↗

Active Phase 3

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

Pterygium
Cloudbreak Therapeutics, LLC · started 2022-06-30

📍 Chandigarh · Ahmedabad · Bangalore · Bhubaneswar · Bikaner · Noida

NCT05456425 on ClinicalTrials.gov ↗

Recruiting

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto · started 2021-11-01

📍 Ahmedabad

NCT04754022 on ClinicalTrials.gov ↗

Recruiting

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
AstraZeneca · started 2018-02-17

📍 Ahmedabad · Kolkata · Mumbai

NCT03549754 on ClinicalTrials.gov ↗

Active Phase 3

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

Non Small Cell Lung Carcinoma NSCLC
AstraZeneca · started 2015-11-03

📍 Ahmedabad · Bangalore · Chennai · Gurgaon · Karamsad · New Delhi

NCT02542293 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

New Delhi · 19 Mumbai · 18 Hyderabad · 17 Bangalore · 14 Kolkata · 11 Nagpur · 11 Chandigarh · 9 Jaipur · 9 Ahmedabad · 8 Belagavi · 7 Pune · 7 Kochi · 6

Browse by condition

Heart Failure · 4 Chronic Obstructive Pulmonary Dis… · 2 Tuberculosis · 2 Breast Cancer · 2

Cite this page

Priya Life Science (2026). Clinical Trials in India Tracker. Available at: https://priyalifescience.com/clinical-trials-india/city/ahmedabad (Accessed: 13 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Indian site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.